Search Results

The AMM method is an in vitro diagnostic test for the quantitative measurement of ammonia in human plasma on the Dimension Vista® System. Ammonia measurements are used in the diagnosis and treatment of severe liver disorders such as cirrhosis, hepatitis and Reye's syndrome.

The CHEM 3 CAL is an in vitro diagnostic product for the calibration of Ammonia (AMM), Carbon Dioxide (CO2) and Ethyl Alcohol (ETOH) methods on the Dimension Vista" System.

The Dimension Vista® Ammonia assay (AMM) is an enzymatic method that uses glutamate dehydrogenase (GLDH) and a stabilized NADPH analog. Ammonia reacts with a-ketoglutarate and reduced cofactor to form L-glutamate and the cofactor. The reaction is catalyzed by glutamate dehydrogenase. The decrease in absorbance due to the oxidation of the reduced cofactor is monitored at 340/700 nm and is proportional to the ammonia concentration.

The Dimension Vista® Ammonia (AMM) Flex® reagent cartridge is an in vitro diagnostic device that consists of prepackaged reagents in a plastic cartridge for use on the Dimension Vista® System.

The Dimension Vista® Chemistry 3 Calibrator (CHEM 3 CAL) is a two level, liquid calibrator. It is packaged as a kit of six vials with 2.5 mL per vial. The product is a multi-analyte, aqueous product containing ammonium bicarbonate, sodium carbonate and ethyl alcohol.

The provided document describes the Siemens Dimension Vista® Ammonia Flex® reagent cartridge (AMM) and Dimension Vista® Chemistry 3 Calibrator (CHEM 3 CAL) and their performance characteristics. As a laboratory assay and calibrator, the concept of "acceptance criteria" and "device performance" relates to analytical performance metrics rather than diagnostic accuracy as would be the case for an AI medical device. Similarly, concepts like "sample size used for the test set," "data provenance," "number of experts," "adjudication method," "MRMC comparative effectiveness study," "standalone performance," and "ground truth" are not directly applicable in the context of validating an in vitro diagnostic reagent and calibrator kit.

However, I can extract the relevant analytical performance characteristics and compare them to accepted standards (often implied by the CLSI guidelines referenced).

Here's an interpretation of the requested information, adapted to the context of an in vitro diagnostic (IVD) reagent and calibrator:

Acceptance Criteria and Study to Prove Device Meets Criteria

The studies conducted for the Siemens Dimension Vista® Ammonia Flex® reagent cartridge (AMM) and Dimension Vista® Chemistry 3 Calibrator (CHEM 3 CAL) evaluate their analytical performance against established guidelines (primarily CLSI standards). The 'acceptance criteria' are generally understood to be meeting these established analytical performance benchmarks to demonstrate substantial equivalence to predicate devices and ensure reliable test results.

1. Table of Acceptance Criteria and Reported Device Performance

2. Sample Size Used for the Test Set and the Data Provenance

• Method Comparison: 100 patient samples. Provenance is not explicitly stated (e.g., country of origin) but inferred to be clinical laboratory samples. Data type is prospective, as fresh samples were tested.
• Plasma Equivalency: 49 fresh matched lithium heparin and EDTA plasma samples. Provenance is not explicitly stated. Data type is prospective.
• Precision: Not explicitly stated as "sample size" in the context of unique patient samples, but testing involved "three levels of Liquicheck™ Ethanol/Ammonia control" tested over 20 days, two separate runs with two test samples for each test material (effectively 3 levels * 20 days * 2 runs * 2 replicates = 240 measurements for each level during repeatability and within-lab assessment).
• Linearity, LoB, LoD, LoQ: The number of unique patient samples is not specified. Studies utilized specific control materials and diluted samples tested across multiple days, runs, and replicates (e.g., for LoB, 4 blank samples tested for 3 days, 1 run/day, 2 replicates/run).
• Interference: Tested with specific concentrations of interfering substances (e.g., 75 mg/dL Hemoglobin) and tested at two analyte concentrations (85 µg/dL and 426 µg/dL). The number of unique patient samples for interference testing is not explicitly stated for all tests, but for certain endogenous interferents which exceeded 10% bias, an aliquot of a patient sample containing the potential interferent was mixed with a plasma pool.

Data provenance is from laboratory studies performed at Siemens Healthcare Diagnostics, Inc. on Dimension Vista® 1500 System, implying a retrospective analysis of collected lab data or controlled prospective lab studies.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts

This concept is not applicable to the validation of an IVD reagent and calibrator. The "ground truth" for analytical performance studies is typically established by:

• The results from a legally marketed predicate device (for method comparison).
• Defined reference materials (e.g., control solutions, calibrators).
• Known concentrations in spiked samples.
• Established clinical laboratory reference intervals.

4. Adjudication Method for the Test Set

Not applicable. This concept relates to expert consensus in interpreting complex data (e.g., images) to establish a "ground truth" for a diagnostic model, which is not relevant for analytical performance studies of a laboratory reagent.

5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was Done

Not applicable. MRMC studies are used for diagnostic devices that involve human interpretation of results (e.g., radiology images). This document describes an automated laboratory assay. The closest equivalent is the "Method Comparison" study, which compares the new device's analytical results to those of an established predicate device.

• Effect size of human readers improvement with AI vs. without AI assistance: Not applicable, as no human-in-the-loop AI component is demonstrated.

6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was Done

Yes, the studies presented are all "standalone" in the sense that they evaluate the analytical performance of the assay and calibrator on the Dimension Vista® System without direct human judgment influencing the output of the measurement. The results reported (e.g., correlation, precision, linearity) represent the performance of the device itself.

7. The Type of Ground Truth Used

• Method Comparison: The predicate device, Dimension® Ammonia (AMON) assay (K863840), served as the reference or "ground truth" for comparison.
• Plasma Equivalency: Matched samples of different plasma types were compared, with one type serving as a reference point.
• Precision: Standardized control materials (Liquicheck™ Ethanol/Ammonia control) with known or expected ranges.
• Linearity, LoB, LoD, LoQ: Serial dilutions of samples with known concentrations or blank samples, evaluated against expected analytical behavior.
• Interference: Control samples without interferent compared to test samples with known concentrations of potential interferents.
• Reference Interval: Transference of reference interval from widely accepted literature (Textbook of Clinical Chemistry by NW Tietz) and validated through CLSI C28-A3 guidelines.

8. The Sample Size for the Training Set

Not applicable. This device is an IVD reagent and calibrator, not an AI/ML algorithm that requires a "training set" in the computational sense. The development of such reagents involves chemical and enzymatic research, formulation, and optimization rather than data-driven machine learning training.

9. How the Ground Truth for the Training Set Was Established

Not applicable, as there is no "training set" in the context of an AI/ML algorithm. The "ground truth" for performance evaluations (as described in point 7) is based on established analytical chemistry principles, predicate device performance, and reference materials.

Ask a specific question about this device